Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDUCED PSYCHOSIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 58 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gimenez-Roldan, S; Mateo, D; Navarro, E; Gines, MM
      Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis

      PARKINSONISM & RELATED DISORDERS
    2. Wolters, EC; Berendse, HW
      Management of psychosis in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    3. Larsen, JP; Tandberg, E
      Sleep disorders in patients with Parkinson's disease - Epidemiology and management

      CNS DRUGS
    4. Adler, LE; Olincy, A; Cawthra, E; Hoffer, M; Nagamoto, HT; Amass, L; Freedman, R
      Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism

      NEUROPSYCHOPHARMACOLOGY
    5. Mark, MH
      Lumping and splitting the Parkinson plus syndromes - Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration

      NEUROLOGIC CLINICS
    6. Ginsberg, DL; Sussman, N
      Gabapentin as prophylaxis against steroid-induced mania

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    7. Sa, DS; Kapur, S; Lang, AE
      Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis

      CLINICAL NEUROPHARMACOLOGY
    8. Bayas, A; Kornhuber, J; Naumann, M
      Atypical neuroleptics and new antidepressants in the treatment of neurological disorders

      AKTUELLE NEUROLOGIE
    9. Djibo, A; Lawan, A
      Behavioural disorders during treatment with isoniazid.

      BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
    10. Brune, M; Gerlach, G; Schroder, SG
      A case of delusional jealousy in Parkinson's disease

      NERVENARZT
    11. Lahti, AC; Warfel, D; Michaelidis, T; Weiler, MA; Frey, K; Tamminga, CA
      Long-term outcome of patients who receive ketamine during research

      BIOLOGICAL PSYCHIATRY
    12. Linn, GS; Lifshitz, K; O'Keeffe, RT; Lee, K; Camp-Lifshitz, J
      Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of Cebus apella monkeys

      PSYCHOPHARMACOLOGY
    13. Segal, J; Walton, S; Clark, H; Berk, M
      Pharmacotherapy of mania: A review

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    14. Cubells, JF; Kranzler, HR; McCance-Katz, E; Anderson, GM; Malison, RT; Price, LH; Gelernter, J
      A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia

      MOLECULAR PSYCHIATRY
    15. Speed, S; Janikiewicz, SMJ
      Providing care to drug users on Wirral: a case study analysis of a PrimaryHealth Care/General Practice-Led Drug Service

      DRUGS-EDUCATION PREVENTION AND POLICY
    16. Henderson, MJ; Mellers, JDC
      Psychosis in Parkinson's disease: 'between a rock and a hard place'

      INTERNATIONAL REVIEW OF PSYCHIATRY
    17. Jansen, KLR
      A review of the nonmedical use of ketamine: Use, users and consequences

      JOURNAL OF PSYCHOACTIVE DRUGS
    18. Ma, JY; Leung, LWS
      Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine

      BEHAVIOURAL BRAIN RESEARCH
    19. Wada, K; Yamada, N; Suzuki, H; Lee, YM; Kuroda, S
      Recurrent cases of corticosteroid-induced mood disorder: Clinical characteristics and treatment

      JOURNAL OF CLINICAL PSYCHIATRY
    20. Patten, SB; Neutel, CI
      Corticosteroid-induced adverse psychiatric effects - Incidence, diagnosis and management

      DRUG SAFETY
    21. Fujimura, M; Hashimoto, K; Yamagami, K
      Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Fenelon, G; Mahieux, F; Huon, R; Ziegler, M
      Hallucinations in Parkinson's disease - Prevalence, phenomenology and riskfactors

      BRAIN
    23. Depoortere, R; Perrault, G; Sanger, DJ
      Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex

      BEHAVIOURAL PHARMACOLOGY
    24. Krystal, JH; Belger, A; D'Souza, DC; Anand, A; Charney, DS; Aghajanian, GK; Moghaddam, B
      Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists

      NEUROPSYCHOPHARMACOLOGY
    25. Martinez, ZA; Ellison, GD; Geyer, MA; Swerdlow, NR
      Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

      NEUROPSYCHOPHARMACOLOGY
    26. Jentsch, JD; Taylor, JR; Elsworth, JD; Redmond, DE; Roth, RH
      Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: Involvement in frontostriatal cognitive deficits

      NEUROSCIENCE
    27. Leweke, FM; Emrich, HM
      Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    28. Preda, A; Fazeli, A; McKay, BG; Bowers, MB; Mazure, CM
      Lamotrigine as prophylaxis against steroid-induced mania

      JOURNAL OF CLINICAL PSYCHIATRY
    29. Friedman, J; Lannon, M; Comella, C; Factor, S; Kurlan, R; Richard, I; Parsa, M; Pfeiffer, R; Davies, R; Janko, K; Brown, D; Gardner, I; Pearson, N; Large, K; Rast, S; Oakes, D; Goetz, C; Paulson, G; Marshall, F; Kieburtz, K; Rudolph, A; Bourgeois, K; Casacelli, C; Freimuth, A; Guthrie, B; Pelusio, R; Watts, A; Tariot, P; Raubertas, R; Greenamyre, T
      Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease

      NEW ENGLAND JOURNAL OF MEDICINE
    30. Carpenter, WT
      The schizophrenia ketamine challenge study debate

      BIOLOGICAL PSYCHIATRY
    31. Krystal, JH; D'Souza, DC; Karper, LP; Bennett, A; Abi-Dargham, A; Abi-Saab, D; Cassello, K; Bowers, MB; Vegso, S; Heninger, GR; Charney, DS
      Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

      PSYCHOPHARMACOLOGY
    32. SEEMAN P; TALLERICO T
      ANTIPSYCHOTIC-DRUGS WHICH ELICIT LITTLE OR NO PARKINSONISM BIND MORE LOOSELY THAN DOPAMINE TO BRAIN D2 RECEPTORS, YET OCCUPY HIGH-LEVELS OFTHESE RECEPTORS

      Molecular psychiatry
    33. ISKEDJIAN M; HUX M; REMINGTON GJ
      THE CANADIAN EXPERIENCE WITH RISPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA - AN OVERVIEW

      Journal of psychiatry & neuroscience
    34. BROWN ES; SUPPES T
      MOOD SYMPTOMS DURING CORTICOSTEROID-THERAPY - A REVIEW

      Harvard review of psychiatry
    35. Beshay, H; Pumariega, AJ
      Sertraline treatment of mood disorder associated with prednisone: A case report

      JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    36. ROSS DL
      FACTORS ASSOCIATED WITH EXCITED DELIRIUM DEATHS IN POLICE CUSTODY

      Modern pathology
    37. FLAHERTY JH
      COMMONLY PRESCRIBED AND OVER-THE-COUNTER MEDICATIONS - CAUSES OF CONFUSION

      Clinics in geriatric medicine
    38. YOUNG BK; CAMICIOLI R; GANZINI L
      NEUROPSYCHIATRIC ADVERSE-EFFECTS OF ANTIPARKINSONIAN DRUGS - CHARACTERISTICS, EVALUATION AND TREATMENT

      Drugs & aging
    39. JIMENO N; JIMENO A; LOPEZ MN; VARGAS ML
      A PSYCHOPATHOLOGICAL STUDY OF SUBSTANCE-INDUCED PSYCHOSES IN A SAMPLEOF SPANISH PATIENTS

      European addiction research
    40. FACTOR SA; FRIEDMAN JH
      THE EMERGING ROLE OF CLOZAPINE IN THE TREATMENT OF MOVEMENT-DISORDERS

      Movement disorders
    41. OZSANCAK C; AUZOU P; RONZIERE T; HANNEQUIN D; AUGUSTIN P
      CLOZAPINE AS A TREATMENT OF PSYCHOSIS IN PARKINSONS-DISEASE

      La Presse medicale
    42. RETZ W; ROSLER M; SITZMANN L; BECKER T
      CLOZAPINE TREATMENT IN GERIATRIC-PATIENTS

      Fortschritte der Neurologie, Psychiatrie
    43. DUBOVSKY SL; BUZAN RD
      NOVEL ALTERNATIVES AND SUPPLEMENTS TO LITHIUM AND ANTICONVULSANTS FORBIPOLAR AFFECTIVE-DISORDER

      The Journal of clinical psychiatry
    44. LIFSHITZ K; OKEEFFE RT; LINN GS; LEE KL; CAMPBRUNO JA; SUCKOW RF
      EFFECTS OF DOPAMINE AGONISTS ON CEBUS-APELLA MONKEYS WITH PREVIOUS LONG-TERM EXPOSURE TO FLUPHENAZINE

      Biological psychiatry
    45. ZILLESSEN KE; TROTT GE; WARNKE A
      INDUCED DELUSIONAL DISORDER IN CHILDREN A ND ADOLESCENTS

      Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie
    46. THOMAS RJ; REAGAN DR
      ASSOCIATION OF A TOURETTE-LIKE SYNDROME WITH OFLOXACIN

      The Annals of pharmacotherapy
    47. YUI K; GOTO K; IKEMOTO S; ISHIGURO T
      PLASMA MONOAMINE METABOLITES AND SPONTANEOUS RECURRENCE OF METHAMPHETAMINE-INDUCED PARANOID-HALLUCINATORY PSYCHOSIS - RELATION OF NORADRENERGIC ACTIVITY TO THE OCCURRENCE OF FLASHBACKS

      Psychiatry research
    48. FISHMAN SM; CATARAU EM; SACHS G; STOJANOVIC M; BORSOOK D
      CORTICOSTEROID-INDUCED MANIA AFTER SINGLE REGIONAL APPLICATION AT THECELIAC PLEXUS

      Anesthesiology
    49. AUZOU P; OZSANCAK C; HANNEQUIN D; MOORE N; AUGUSTIN P
      CLOZAPINE FOR THE TREATMENT OF PSYCHOSIS IN PARKINSONS-DISEASE - A REVIEW

      Acta neurologica Scandinavica
    50. IKEGUCHI K; KURODA A
      MIANSERIN TREATMENT OF PATIENTS WITH PSYCHOSIS INDUCED BY ANTIPARKINSONIAN DRUGS

      European archives of psychiatry and clinical neuroscience
    51. SWARTZ CM
      TARDIVE PSYCHOPATHOLOGY

      Neuropsychobiology
    52. KASPER S; JUNG B
      PSYCHOPATHOLOGICAL SIDE-EFFECTS OF NONPSY CHOPHARMACOLOGICAL PHARMACOTHERAPY

      Nervenarzt
    53. HEINZ A; PRZUNTEK H; WINTERER G; PIETZCKER A
      CLINICAL COURSE OF DOPAMINE-INDUCED PSYCH OSES UNDER CONTINUOUS DOPAMINERGIC THERAPY AND THE IMPLICATIONS FOR THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA

      Nervenarzt
    54. YOUSEF G; HUG Z; LAMBERT T
      KHAT CHEWING AS A CAUSE OF PSYCHOSIS

      British Journal of Hospital Medicine
    55. MENDIS T; MOHR E; GEORGE A; RUSK IN; GRAY P; GRIMES JD
      SYMPTOMATIC RELIEF FROM TREATMENT-INDUCED PSYCHOSIS IN PARKINSONS-DISEASE - AN OPEN-LABEL PILOT-STUDY WITH REMOXIPRIDE

      Movement disorders
    56. CASSIDY G; BALLARD CG
      PSYCHIATRIC SEQUELAE OF MDMA (ECSTASY) AND RELATED DRUGS

      Irish journal of psychological medicine
    57. PINTER MM; HELSCHER RJ
      THERAPEUTIC EFFECT OF CLOZAPINE IN PSYCHOTIC DECOMPENSATION IN IDIOPATHIC PARKINSONS-DISEASE

      Journal of neural transmission. Parkinson's disease and dementia section
    58. SILVA RR; FRIEDHOFF AJ; ALPERT M
      NEUROLEPTIC WITHDRAWAL PSYCHOSIS IN TOURETTES DISORDER

      Biological psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 04:05:47